Showing results (1991-2000 of 4,544) with videos related to

Sort By:
Pageof 455
Neoplasma|January 1, 1987
Modification by caffeine of acute cytotoxic response of cultured L5178Y cells to hydroxyurea treatmentJ Sawecka, B Gołos, J Malec
Neoplasma|January 1, 1987
Further characterization of the leukemogenic activity of haloperidol in miceV Wunderlich, F Fey, G Sydow
Neoplasma|January 1, 1987
Relationship of some biosocial factors to colon cancer in Belgrade (Yugoslavia)H Vlajinac, M Jarebinski, B Adanja
Neoplasma|January 2, 2023
LncRNA CBR3-AS1 predicts a poor prognosis and promotes cervical cancer progression through the miR-3163/LASP1 pathwayYipin Cai, Yu Huang, Jie Zhang, et al.
Neoplasma|January 20, 2023
Semaphorin 3A inhibits tumor progression via the downregulation of Lin28B in ovarian cancerRu-Yue Ma, Li-Na Yang, Ji-Na Chen, et al.
Neoplasma|January 13, 2023
Zerumbone combined with gefitinib alleviates lung cancer cell growth through the AKT/STAT3/SLC7A11 axisJin-Guo Wang, Da-Lei Li, Rong Fan, et al.
Neoplasma|July 1, 2021
Determining the effects of Ephrin Type B Receptor 6 and Type A Receptor 3 on facilitating colorectal epithelial cell malignant transformationJiaming Wang, Yan Zhang, Jiaao Ma, et al.
Neoplasma|June 7, 2021
Differential Expression of Novel Immune Checkpoint Receptors on Tumor Infiltrating Lymphocytes in Patients with Locally Advanced Breast Cancer after Neoadjuvant ChemotherapyAykhan Abbasov, Esin Aktas Cetin, Neslihan Cabioglu, et al.
Neoplasma|May 9, 2022
LIMD2 promotes tumor proliferation, invasion, and epithelial-mesenchymal transition in clear cell renal cell carcinomaQi-Yu Zhong, Ying-Wei Xie, Zhi-Liang Chen, et al.
Neoplasma|September 17, 2020
Long-term clinical benefit of Peg-IFNα and NAs sequential anti-viral therapy on HBV related HCCWen-Qian Qi, Qian Zhang, Xu Wang, et al.
Pageof 455